Notch signaling: Emerging molecular targets for cancer therapy

Research output: Contribution to journalReview articlepeer-review

143 Scopus citations


The Notch signaling pathway is a highly conserved developmental pathway, which plays a critical role in cell-fate decision, tissue patterning and morphogenesis. There is increasing evidence that this pathway is dysregulated in a variety of malignancies, and can behave as either an oncogene or a tumor suppressor depending upon cell context. This review highlights the current evidence for aberration of the Notch signaling pathway in a wide range of tumors from hematological cancers, such as leukemia and lymphoma through to skin, breast, lung, pancreas, colon and brain tumors. It proposes that the Notch signaling pathway may represent novel therapeutic targets and will be a welcome asset to the cancer therapeutic arena.

Original languageEnglish (US)
Pages (from-to)690-701
Number of pages12
JournalBiochemical Pharmacology
Issue number5
StatePublished - Sep 2010


  • Cancer therapeutics
  • Notch
  • Signal transduction
  • Tumor
  • Tumor angiogenesis

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry


Dive into the research topics of 'Notch signaling: Emerging molecular targets for cancer therapy'. Together they form a unique fingerprint.

Cite this